Atrial fibrillation is an epidemic in Asia that is increasingly prevalent. Apart from stroke risk stratification and management of anticoagulation, physicians managing this group of patients also need to determine an optimal strategy in terms of rate or rhythm control. With new techniques of catheter ablation to maintain patients in sinus rhythm, patients with atrial fibrillation now have more options for treatment, on top of pharmacological methods. This paper aims to review the current evidence for rate and rhythm control in both general patients and subgroups of interest commonly encountered in clinical practices such as obesity, heart failure and thyroid disease.
Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia. The prevalence rate of AF in the adult population is 1% in most Asian countries, with an estimated 72 million patients in Asia affected by 2050.
This article is available only as a PDF. Please click on “Download PDF” on top to view the full article.